HMGA1 is a novel candidate gene for myocardial infarction susceptibility

International Journal of Cardiology

Volumn 227, Issue , 2017, Pages 331-334

  De Rosa, Salvatore ^a   Chiefari, Eusebio ^a   Salerno, Nadia ^a   Ventura, Valeria ^a   D'Ascoli, Greta Luana ^a   Arcidiacono, Biagio ^a   Ambrosio, Giuseppe ^a   Bilotta, Francesco Luciano ^a   Torella, Daniele ^a   Foti, Daniela ^a   Indolfi, Ciro ^a,b   Brunetti, Antonio ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b CNR   (Italy)

Author keywords

Acute myocardial infarction; Diabetes; Polymorphism; Risk factors

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE; AGED; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENDER; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HMGA1 GENE; HUMAN; HYPERTENSION; ITALY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SEX; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HEART INFARCTION; MIDDLE AGED;

HIGH MOBILITY GROUP A1A PROTEIN;

AGED; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HMGA1A PROTEIN; HUMANS; ITALY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC;

EID: 85003875617     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.11.088     Document Type: Article

References (28)

1. [1] Mozaffarian, D., Benjamin, E.J., Go, A.S., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Heart disease and stroke statistics-2016 update: a report from the American Heart Association. Circulation 133 (2016), e38–e360.
2. [2] Goncalves, I., Bengtsson, E., Colhoun, H.M., et al., Summit Consortium, Elevated plasma levels of MMP-12 are associated with atherosclerotic burden and symptomatic cardiovascular disease in subjects with type 2 diabetes. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1723–1731.
3. [3] Van Dijk, R.A., Duinisveld, A.J., Schaapherder, A.F., et al. A change in inflammatory footprint precedes plaque instability: a systematic evaluation of cellular aspects of the adaptive immune response in human atherosclerosis. J. Am. Heart Assoc., 4, 2015.
4. [4] Kannel, W.B., McGee, D.L., Diabetes and cardiovascular disease. JAMA 241 (1979), 2035–2038.
5. [5] Tierney, E.F., Geiss, L.S., Engelgau, M.M., et al. Population-based estimates of mortality associated with diabetes: use of a death certificate check box in North Dakota. Am. J. Public Health, 91, 2001, 84.
6. [6] Bornfeldt, K.E., Tabas, I., Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 14 (2011), 575–585.
7. [7] Muniyappa, R., Sowers, J.R., Role of insulin resistance in endothelial dysfunction. Rev. Endocr. Metab. Disord. 14 (2013), 5–12.
8. [8] Crea, F., Liuzzo, G., Pathogenesis of acute coronary syndromes. J. Am. Coll. Cardiol. 61 (2013), 1–11.
9. [9] Roberts, R., Stewart, A.F., Genes and coronary artery disease: where are we?. J. Am. Coll. Cardiol. 60 (2012), 1715–1721.
10. [10] Bustin, M., Reeves, R., High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog. Nucleic Acid Res. Mol. Biol. 54 (1996), 35–100.
11. [11] Foti, D., Chiefari, E., Fedele, M., et al. Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat. Med. 11 (2005), 765–773.
12. [12] Chiefari, E., Iiritano, S., Paonessa, F., et al. Pseudogene-mediated posttranscriptional silencing of HMGA1 can result in insulin resistance and type 2diabetes. Nat. Commun. 1 (2010), 1–7.
13. [13] Bianco, A., Chiefari, E., Nobile, C.G.A., Foti, D.P., Pavia, M., Brunetti, A., The association between HMGA1 rs146052672 variant and type 2 diabetes: a transethnic meta-analysis. PLoS One, 10, 2015, e0136077.
14. [14] Chiefari, E., Tanyolaç, S., Iiritano, S., et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci. Rep., 3, 2013, 1491.
15. [15] Cleynen, I., Van de Venn, W.J., The HMGA proteins: a myriad of functions. Int. J. Oncol. 32 (2008), 289–305.
16. [16] Schlueter, C., Hauke, S., Loeschke, S., Wenk, H.H., Bullerdiek, J., HMGA1 proteins in human atheroscleroticplaques. Pathol. Res. Pract. 201 (2005), 101–107.
17. [17] Foster, L.C., Wiesel, P., Huggins, G.S., et al. Role of activating protein-1 and high mobility group-I(Y) protein in the induction of CD44 gene expression by interleukin-1beta in vascular smooth muscle cells. FASEB J. 14 (2000), 368–378.
18. [18] Melillo, R.M., Pierantoni, G.M., Scala, S., et al. Critical role of the HMGI(Y) proteins in adipocytic cell growth and differentiation. Mol. Cell. Biol. 21 (2001), 2485–2495.
19. [19] Treff, N.R., Pouchnik, D., Dement, G.A., Britt, R.L., Reeves, R., High-mobility group A1a protein regulates Ras/ERK signaling in MCF–7 human breast cancer cells. Oncogene 23 (2004), 777–785.
20. [20] Bloch, M., Prock, A., Paonessa, F., et al. High-mobility group A1 protein: a new coregulator of peroxisome proliferator-activated receptor-γ-mediated transrepression in the vasculature. Circ. Res. 110 (2012), 394–405.
21. [21] Fedele, M., Fidanza, V., Battista, S., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 66 (2006), 2536–2543.
22. [22] Di Gaetano, C., Voglino, F., Guarrera, S., et al. An overview of the genetic structure within the Italian population from genome–wide data. PLoS One, 7, 2012, e43759.
23. [23] Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., Joint ESC/ACCF/AHA/WHF task force for the universal definition of myocardial infarction. Eur. Heart J., 2012.
24. [24] American Diabetes Association, Standards of medical care in diabetes–2015. 2. Classification and diagnosis of diabetes. Diabetes Care 39 (2016), S13–S22.
25. [25] Chiefari, E., Tanyolaç, S., Paonessa, F., et al. Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305 (2011), 903–912.
26. [26] Hock, R., Furusawa, T., Ueda, T., Bustin, M., HMG chromosomal proteins in development and disease. Trends Cell Biol. 17 (2007), 72–79.
27. [27] Fedele, M., Visone, R., De Martino, I., et al. Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. Eur. J. Cancer 47 (2011), 470–478.
28. [28] Barter, P., Gotto, A.M., La Rosa, J.C., et al. Treating to new targets investigators. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. N. Engl. J. Med. 35 (2007), 1301–1310.